HCW news

Latest 2 stories · newest Jun 26, 2026

HCW

HCW Biologics adopts 1-for-6 reverse stock split

HCW Biologics implemented a 1-for-6 reverse stock split effective June 30, 2026. This corporate action aims to increase the share price to meet listing requirements and enhance marketability.

Restructuring Jun 26, 2026 sentiment 0.00 SEC filing ↗

HCW

HCW Biologics issues pre-funded warrant agreement for common stock purchase

HCW Biologics Inc. filed a pre-funded warrant form allowing holders to purchase common shares at a specified exercise price beginning in 2026. The warrant issuance represents a capital raising mechanism typically used in equity financings for growth-stage biotech companies.

Offering May 21, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same HCW feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/HCW/newsSTART FREE